Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Anemia

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    November 2018
  1. GANZ T
    Erythropoietin and iron-a conflicted alliance?
    Kidney Int. 2018;94:851-853.
    PubMed     Text format     Abstract available


    September 2018
  2. SUZUKI N, Matsuo-Tezuka Y, Sasaki Y, Sato K, et al
    Iron attenuates erythropoietin production by decreasing hypoxia-inducible transcription factor 2alpha concentrations in renal interstitial fibroblasts.
    Kidney Int. 2018 Sep 20. pii: S0085-2538(18)30515.
    PubMed     Text format     Abstract available


    June 2018
  3. ANUSORNVONGCHAI T, Nangaku M, Jao TM, Wu CH, et al
    Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response.
    Kidney Int. 2018 Jun 7. pii: S0085-2538(18)30250.
    PubMed     Text format     Abstract available


    January 2018
  4. TORO L, Barrientos V, Leon P, Rojas M, et al
    Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30854.
    PubMed     Text format     Abstract available


    July 2017
  5. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


    June 2017
  6. SUGAHARA M, Tanaka T, Nangaku M
    Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30305.
    PubMed     Text format     Abstract available


  7. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Text format     Abstract available


    March 2017
  8. GOODSHIP TH, Cook HT, Fakhouri F, Fervenza FC, et al
    Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Kidney Int. 2017;91:539-551.
    PubMed     Text format     Abstract available


    November 2016
  9. RHEAULT MN, Molony JT, Nevins T, Herzog CA, et al
    Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Kidney Int. 2016 Nov 16. pii: S0085-2538(16)30539.
    PubMed     Text format     Abstract available


  10. WYATT CM, Drueke TB
    HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Kidney Int. 2016;90:923-925.
    PubMed     Text format     Abstract available


    September 2016
  11. PERGOLA PE, Spinowitz BS, Hartman CS, Maroni BJ, et al
    Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Kidney Int. 2016 Sep 17. pii: S0085-2538(16)30357.
    PubMed     Text format     Abstract available


    July 2016
  12. VANKALAKUNTI M, Vasavi B, Anitha A
    Intravascular large B-cell lymphoma: masquerade as membranoproliferative glomerulonephritis.
    Kidney Int. 2016;90:231-2.
    PubMed     Text format    


    May 2016
  13. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    PubMed     Text format     Abstract available


    March 2016
  14. GREENBAUM LA, Fila M, Ardissino G, Al-Akash SI, et al
    Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Kidney Int. 2016;89:701-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: